Cancer BiologybioRxivPreprint
Rbbp8nl contributes to resistance to anticancer immunotherapy by creating a non-inflamed tumor microenvironment and attenuating CD8+ T cell infiltration
Zhenglin Yi, Jinhui Liu, Hao Deng…·Xiongbing Zu
This study identifies RBBP8NL as a factor that reduces immune response in tumors by creating a non-inflammatory microenvironment and limiting CD8+ T cell infiltration, suggesting it as a target for improving immunotherapy.
DOI 10.1101/2024.01.21.575810